Biological Drug Products: Development and Strategies

Book information

Publisher
Wiley
Year
2013
ISBN
1118695224, 9781118695227
LCC
2013016910
Google Books ID
4UiaAAAAQBAJ
Format
PDF
Filesize
18 MB (18923934 bytes)
Edition
unabridged
Pages
744\746
Orientation
portrait
Paginated
yes
Scanned
no
Time added
2015-02-06 11:55:12

Description

Tested and proven solutions to the challenges of biological drug product developmentBiological drug products play a central role in combating human diseases; however, developing new successful biological drugs presents many challenges, including labor intensive production processes, tighter regulatory controls, and increased market competition. This book reviews the current state of the science, offering readers a single resource that sets forth the fundamentals as well as tested and proven development strategies for biological drugs. Moreover, the book prepares readers for the challenges that typically arise during drug development, offering straightforward solutions to improve their ability to pass through all the regulatory hurdles and deliver new drug products to the market."Biological Drug Products" begins with general considerations for the development of any biological drug product and then explores the strategies and challenges involved in the development of specific types of biologics. Divided into five parts, the book examines: Part 1: General AspectsPart 2: Proteins and PeptidesPart 3: VaccinesPart 4: Novel BiologicsPart 5: Product Administration/DeliveryEach chapter has been prepared by one or more leading experts in biological drug development. Contributions are based on a comprehensive review and analysis of the current literature as well as the authors' first-hand experience developing and testing new drugs. References at the end of each chapter serve as a gateway to original research papers and reviews in the field.By incorporating lessons learned and future directions for research, "Biological Drug Products "enables pharmaceutical scientists and students to improve their success rate in developing new biologics to treat a broad range of human diseases.

Similar books